Ruediger Rueger
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- Vascular Tumors and Angiosarcomas
-
- Melanoma and MAPK Pathways
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
Papers in
-
- Melanoma and MAPK Pathways 6
- Protein Degradation and Inhibitors 2
- Oncology 3
- Cancer-related Molecular Pathways 2
- Co-authors
- Gwen Nichols (3 shared papers)Jianguo Zhi (3 shared papers)Antoîne Italiano (2 shared papers)Florian Heil (2 shared papers)Jean‐Yves Blay (2 shared papers)Nicolas Penel (2 shared papers)Bradford Graves (1 shared paper)David Geho (1 shared paper)
- Journals
- Clinical Cancer Research (3 papers)Journal of Clinical Oncology (2 papers)Molecular Cancer Therapeutics (2 papers)Applied immunohistochemistry & molecular morphology (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- SwitzerlandUnited StatesFrance
In The Last Decade
Ruediger Rueger
12 papers receiving 772 citations
Ruediger Rueger's Hit Papers
Peers
Comparison fields: 5 of 60
- Oncology 361
- Molecular Biology 447
- Pulmonary and Respiratory Medicine 181
- Cancer Research 81
- Pathology and Forensic Medicine 82
Countries citing papers authored by Ruediger Rueger
This map shows the geographic impact of Ruediger Rueger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruediger Rueger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruediger Rueger more than expected).
Fields of papers citing papers by Ruediger Rueger
This network shows the impact of papers produced by Ruediger Rueger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruediger Rueger. The network helps show where Ruediger Rueger may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruediger Rueger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study Hit paper breakdown → | 2012 | 460 |
| 2 | 2012 | 125 | |
| 3 | 2012 | 56 | |
| 4 | 2015 | 41 | |
| 5 | 2009 | 30 | |
| 6 | 2009 | 18 | |
| 7 | 2010 | 15 | |
| 8 | 2011 | 10 | |
| 9 | 2017 | 8 | |
| 10 | 2010 | 8 | |
| 11 | 2011 | 6 | |
| 12 | 2010 | 1 |
About Ruediger Rueger
Ruediger Rueger is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Computational Theory and Mathematics and Organic Chemistry, having authored 12 papers that have together received 778 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (6 papers), Protein Degradation and Inhibitors (2 papers), Cancer-related Molecular Pathways (2 papers), Computational Drug Discovery Methods (2 papers), Cancer Mechanisms and Therapy (1 paper), Sarcoma Diagnosis and Treatment (1 paper), Acute Lymphoblastic Leukemia research (1 paper) and Toxin Mechanisms and Immunotoxins (1 paper). The work is most often cited by research in Oncology (361 citations), Molecular Biology (447 citations), Pulmonary and Respiratory Medicine (181 citations), Cancer Research (81 citations) and Pathology and Forensic Medicine (82 citations). Ruediger Rueger has collaborated with scholars based in Switzerland, United States and France. Frequent co-authors include Gwen Nichols, Jianguo Zhi, Antoîne Italiano, Florian Heil, Jean‐Yves Blay, Nicolas Penel, Bradford Graves, David Geho, Isabelle Ray‐Coquard and Lyubomir T. Vassilev. Their work appears in journals such as Clinical Cancer Research, Journal of Clinical Oncology, Molecular Cancer Therapeutics, Applied immunohistochemistry & molecular morphology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.